Cardio Diagnostics: AI-Driven Precision in Cardiovascular Care

Cardio Diagnostics Holdings (NASDAQ: CDIO) is at the forefront of a revolution in cardiovascular diagnostics, where advances in molecular science and artificial intelligence (AI) are converging to deliver more precise, individualized insights from minimally invasive tests. The company is developing a proprietary platform that integrates epigenetic and genetic biomarkers with AI to generate personalized cardiovascular risk assessments from a simple blood sample. At the core of Cardio Diagnostics’ approach is the use of AI to integrate multi-omic data, specifically epigenetic markers such as DNA methylation with genetic information, to provide a more comprehensive view of cardiovascular health. Traditional diagnostic tools often rely on population-based risk factors such as cholesterol levels, blood pressure and family history. While these indicators are valuable, they may not fully capture individualized disease risk or early molecular changes that precede clinical symptoms. By contrast, epigenetic biomarkers reflect how environmental and lifestyle factors influence gene expression, offering a dynamic layer of insight that evolves over time.

Cardio Diagnostics is an AI-powered precision cardiovascular medicine company that aims to make cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company was formed to further develop and commercialize clinical tests by leveraging its proprietary AI-driven Integrated Genetic-Epigenetic Engine (Core Technology) for cardiovascular disease, with the goal of becoming one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For the latest news and updates relating to CDIO, visit the company’s newsroom at https://ibn.fm/CDIO.

BioMedWire (BMW), a specialized communications platform focusing on the latest developments in the Biotechnology, Biomedical Sciences, and Life Sciences sectors, is one of 75+ brands within the Dynamic Brand Portfolio @ IBN. BMW delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN to millions of followers, and a full array of tailored corporate communications solutions. With a broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public.